Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia

Belal A. Kassem, Fawaz A. Shaik, Omar Sorour, Alaa Abdelhamid, Alysse Fazal, Ali H. Dakroub, Ali H. Eid

Open source

DOI: 10.1097/fjc.0000000000001846
Published: 2026-07-20
Container: Journal of Cardiovascular Pharmacology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/fjc.0000000000001846,
  title = {Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia},
  author = {Belal A. Kassem and Fawaz A. Shaik and Omar Sorour and Alaa Abdelhamid and Alysse Fazal and Ali H. Dakroub and Ali H. Eid},
  year = {2026},
  journal = {Journal of Cardiovascular Pharmacology},
  doi = {10.1097/fjc.0000000000001846},
  url = {https://doi.org/10.1097/fjc.0000000000001846}
}

RIS

TY  - JOUR
TI  - Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia
AU  - Belal A. Kassem
AU  - Fawaz A. Shaik
AU  - Omar Sorour
AU  - Alaa Abdelhamid
AU  - Alysse Fazal
AU  - Ali H. Dakroub
AU  - Ali H. Eid
PY  - 2026
JO  - Journal of Cardiovascular Pharmacology
DO  - 10.1097/fjc.0000000000001846
UR  - https://doi.org/10.1097/fjc.0000000000001846
ER  -

APA

Kassem, B. A., Shaik, F. A., Sorour, O., Abdelhamid, A., Fazal, A., Dakroub, A. H., & Eid, A. H. (2026). Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0000000000001846

Source records

crossref · retrieved 2026-09-26T11:55:09.094Z